YKL-40 - A NEW DIAGNOSTIC BIOMARCER FOR BENIGN BREAST DISEASES AND BREAST CANCER
Benign breast diseases encompass a wide spectrum of lesions, which raise a lot of questions about their classification, diagnosis, prognosis and surgical treatment. The aim of this study is to measure the serum level of YKL-40 in cases of different groups of benign breast diseases, to compare it to...
Saved in:
Main Authors: | Vanya Uzunova (Author), G. Paskalev (Author), Maria Kazakova (Author), E. Poryazova (Author), K. Murdjev (Author), A. Uchikov (Author), A. Iankulov (Author), Victoria Sarafian (Author), D. Manolova (Author), A. Paskaleva (Author), B. Hadjiev (Author), J. Grudeva-Popova (Author) |
---|---|
Format: | Book |
Published: |
Peytchinski Publishing,
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010) -
SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014) -
Study of serum YKL-40 in children with bronchial
by: Iman A. Mohammed, et al.
Published: (2016) -
The value of YKL-40 in ischemic heart disease patients
by: Doaa S.E Zaky, et al.
Published: (2016) -
Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
by: Mohammad Reza Jafari-Nakhjavani, et al.
Published: (2019)